Yüklüyor......
Dose expansion cohorts in Phase I trials
A rapidly increasing number of Phase I dose-finding studies, and in particular those based on the standard 3+3 design, are being prolonged with the inclusion of dose expansion cohorts (DEC) in order to better characterize the toxicity profiles of experimental agents and to study disease-specific coh...
Kaydedildi:
| Yayımlandı: | Stat Biopharm Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976787/ https://ncbi.nlm.nih.gov/pubmed/27516848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2015.1135185 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|